CXCL8 and neoplasm: The location of HMGB1 in the cytoplasm or extracellular space will promote the release of cytokines such as IL-6 and IL-8 by activating MAPK- and MyD88-dependent NF-KB pathways, thereby prompting tumor cell proliferation, angiogenesis, EMT, invasion, and metastasis.